Drug companies and managed care organizations are working to keep prices from rising precipitously. Then there’s Pfizer.
In the first quarter of 2017, pharmaceutical deals dropped even further, compared with the previous quarter, and the same quarter the year before.
The Pharmaceutical sector hasn’t wasted any time getting busy in the New Year. As of January 18, 2017, 10 pharma deals have been announced, with disclosed prices totaling $7.18 billion. Of course, the annual JP Morgan Healthcare Summit, held this year from January 9 to January 13, helped to boost the announcements. The largest deal so […]